The Aggressive Portfolio was born with the objective of energizing new investment ideas among readers week after week with a strong bias towards tradeor what amounts to the same thing, with shorter-term profitability objectives. After several weeks, many investment ideas have already been launched from this new format, although not all of them end up being executed. The last strategy opened was Airtificial. Now, It’s time to buy Immunic.
The new aggressive operation concerns Immunic (Nasdaq: IMUX), a biotechnology company developing a clinical portfolio of oral small molecule therapies for chronic inflammatory and autoimmune diseases. It is an aggressive purchase option outside the national market, waiting for the Ibex Small Caps to break the resistance at 8,335 points to begin to focus again on the Spanish market. If they assume a stop who is a 20% distance at $1.30they can take advantage of the sharp short-term decline to $1.60, which I consider a classic backtracking or return to an old resistance, to buy. We are looking for targets at 2 then 3 dollars.
